Ferencz Garrett sold $7K of TBI

Ferencz Garrett (EVP, Chief Legal Officer) sold 600 shares of TrueBlue, Inc. (TBI) at $12.34 on 2026-11-12.

Original reporting
SEC EDGAR · Ferencz Garrett
Published Nov 16, 2026, 10:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 11:53 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TBI
Neutral
high confidence
Mentioned
$TBI
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TBINeutralLow
01

Why it matters

Insider selling disclosures can influence sentiment at the margin, but without any accompanying guidance, earnings, or operational news, the trading signal is usually weak.

02

Market read

A small, routine insider open-market sale is unlikely to change the company’s valuation or near-term outlook.

03

What to watch

Insider sales can be driven by diversification, tax planning, or pre-existing personal liquidity needs, and the filing provides no rationale or linkage to company fundamentals.

Relevance 3/10Novelty 2/10Timing: filed 2026-11-16, transaction dated 2026-11-12

Background

The article is an SEC Form 4 insider transaction disclosure for TrueBlue, Inc. (TBI).

Company-level read

Ticker impact

$TBINeutralHigh confidence
Context

TrueBlue (TBI) disclosed an insider Form 4 sale by its EVP and Chief Legal Officer, Ferencz Garrett, of 600 shares at $12.34.

Expected impact

Likely minimal near-term price impact; traders may view it as routine profit-taking rather than a signal.

Evidence & confidence

The filing is an insider transaction (Form 4) with a modest dollar value ($7,404) and no accompanying company-specific operational or financial change.

Market effects

No clear sector read-through from a small insider sale disclosure.

None indicated.

None indicated.

Counterpoint

The absence of a pre-arranged 10b5-1 plan could prompt some traders to treat the sale as more informative than typical, even if the dollar amount is small.

Key entities

  • TrueBlue, Inc.

    US-listed company whose insider transaction was reported on Form 4.

  • Ferencz Garrett

    EVP and Chief Legal Officer who sold 600 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TBIMed

What TrueBlue (TBI) Said on Its Q3 Earnings Call

TrueBlue (TBI) reported over $50M in annualized OnSite business wins in Q3, with annualized win volume more than doubling year-over-year. The company forecasted Q4 revenue growth of 20-24%, driven by higher bill rates and growth across all segments. TrueBlue ended Q3 with $20M in cash, $102M in debt, and $86M in total liquidity, expecting positive free cash flow as working capital normalizes.

$TBIHighAI 8/10

TrueBlue Q3 revenue soars 20.7%, driven by growth in PeopleReady unit

TrueBlue (NYSE: TBI) reported Q3 revenue of $520.7M, up 20.7% YoY, driven by its PeopleReady unit, which saw a 34.4% increase. CEO Taryn Owen noted improvement in strategic areas. All divisions showed growth, with PeopleManagement and PeopleSolutions up 1.9% and 0.9%, respectively. Revenue beat estimates and shares rose 20% to $11.85. The company forecasts Q4 revenue of $499M-$519M, a 20-24% YoY increase.

$TBIHighAI 8/10

TrueBlue (TBI) Q3 2026 Earnings Call Transcript

TrueBlue (TBI) reported Q3 2026 revenue of $521M, up 21%, with all segments growing. Energy sector revenue doubled, driving high double-digit growth. Gross margin was 20.5%, down from 22.7% YoY due to revenue mix. Net income was $9M, up from a $2M loss YoY. The company highlighted progress in sales, technology, and cost management, positioning it for further growth.

$TBIHighAI 8/10

Why is TrueBlue stock surging today?

TrueBlue (TBI) stock surged 30.8% in pre-market trading after reporting Q3 2026 earnings that exceeded expectations. Adjusted EPS was $0.33 vs. $0.17 estimate, and revenue was $521M vs. $454M estimate. Baird raised its price target to $15.00 from $9.50, and management guided Q4 revenue growth of 20-24%.

$TBIMedAI 8/10

TrueBlue Inc (TBI) Q3 2026 Earnings Call Highlights: Fifth Straight Quarter of Growth

TrueBlue Inc (TBI) reported Q3 2026 revenue growth of 21%, exceeding guidance. CFO Carl Schweitz noted pay rates rose 1.2% and bill rates 0.4%, driving a 10-basis-point margin decline. Q4 guidance is 20-24% growth, with PeopleReady, PeopleManagement, and PeopleSolutions segments expected to grow 37%, 9%, and 6% respectively. Gross margin declined to 20.5% due to energy work mix. The company expects Q4 profitability improvements and a return to positive free cash flow.